Development of Multi-Photon
Detection Technique and Its Application to Environmental and Biomedical
Diagnostics
BioTraces,
Inc.
Fairfax, VA
BioTraces, Inc.,
Fairfax, VA, used an NIST Advanced Technology Program (ATP) award
to successfully develop the Multi-Photon DetectionTM (MPDTM)
technology for drug discovery and biomedical diagnostics applications.
This ultrasensitive radioanalytical technology is used for the detection
and measurement of biological substances at very low concentrations, with
sensitivity up to 1000-fold better than prior methods. Both BioTraces
and Houston-based PetroTraces, Inc., which holds an exclusive license
for petroleum industry applications (tracing different liquids and gases
that are transported in pipelines), are currently generating revenues
from MPD-based products and services. BioTraces is marketing a
clinical diagnostics device, the ssMPDTM, and has also
established technology evaluation licenses with a major pharmaceutical
company and a leading diagnostics company under which these companies
are evaluating the MPD technology. The technology has applications in
life science research, clinical and food quality diagnostics, and other
select industrial applications.
Click here
to return to ATP Success Stories
Date created: February
1999
Last updated:
April 23, 2003
|
